🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 2 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 19/02/2008 | 44,27 | 44,69 | 43,58 | 43,94 | -0,14% | 2,51% | 1.490.200 |
| 15/02/2008 | 43,97 | 44,32 | 43,38 | 44,00 | -0,36% | 2,13% | 1.077.800 |
| 14/02/2008 | 45,01 | 45,30 | 44,01 | 44,16 | -1,93% | 2,87% | 931.400 |
| 13/02/2008 | 45,98 | 46,02 | 44,50 | 45,03 | -1,33% | 3,31% | 1.433.600 |
| 12/02/2008 | 44,58 | 46,10 | 44,58 | 45,64 | +2,60% | 3,42% | 2.025.600 |
| 11/02/2008 | 43,14 | 44,55 | 43,09 | 44,48 | +2,59% | 3,40% | 1.288.600 |
| 08/02/2008 | 42,98 | 43,60 | 42,42 | 43,36 | +1,21% | 2,75% | 1.000.600 |
| 07/02/2008 | 42,03 | 43,00 | 41,63 | 42,84 | +1,15% | 3,27% | 1.168.600 |
| 06/02/2008 | 43,53 | 43,53 | 42,25 | 42,35 | -1,87% | 2,94% | 1.127.400 |
| 05/02/2008 | 43,00 | 43,92 | 42,85 | 43,16 | -0,95% | 2,48% | 1.013.400 |
| 04/02/2008 | 42,50 | 43,75 | 42,50 | 43,57 | +1,93% | 2,93% | 1.150.400 |
| 01/02/2008 | 42,23 | 43,21 | 42,00 | 42,75 | +1,80% | 2,87% | 1.925.200 |
| 31/01/2008 | 42,14 | 42,37 | 41,65 | 41,99 | -1,51% | 1,70% | 1.702.800 |
| 30/01/2008 | 42,90 | 44,00 | 42,43 | 42,64 | -0,93% | 3,66% | 1.170.600 |
| 29/01/2008 | 43,00 | 43,91 | 42,74 | 43,04 | -0,08% | 2,72% | 1.038.800 |
| 28/01/2008 | 43,01 | 43,51 | 42,41 | 43,07 | -0,15% | 2,57% | 1.057.000 |
| 25/01/2008 | 44,90 | 44,90 | 42,69 | 43,14 | -2,74% | 4,92% | 1.898.800 |
| 24/01/2008 | 45,56 | 46,44 | 44,33 | 44,35 | -2,59% | 4,63% | 1.152.400 |
| 23/01/2008 | 44,79 | 45,56 | 42,56 | 45,53 | +0,40% | 6,70% | 3.293.400 |
| 22/01/2008 | 45,76 | 47,17 | 45,18 | 45,35 | -4,13% | 4,35% | 2.137.200 |
| 18/01/2008 | 46,60 | 47,57 | 46,16 | 47,31 | +1,71% | 3,04% | 3.034.000 |
| 17/01/2008 | 47,84 | 48,23 | 46,51 | 46,51 | -2,23% | 3,59% | 2.040.600 |
| 16/01/2008 | 47,65 | 48,50 | 47,03 | 47,57 | -0,63% | 3,09% | 2.710.400 |
| 15/01/2008 | 48,94 | 48,99 | 47,79 | 47,87 | -2,68% | 2,45% | 1.652.600 |
| 14/01/2008 | 49,58 | 49,64 | 48,70 | 49,19 | -0,13% | 1,91% | 802.200 |
| 11/01/2008 | 49,27 | 49,96 | 48,75 | 49,26 | -1,00% | 2,46% | 2.353.400 |
| 10/01/2008 | 49,50 | 50,03 | 48,31 | 49,76 | +0,63% | 3,47% | 1.309.400 |
| 09/01/2008 | 49,21 | 50,13 | 49,21 | 49,45 | +0,27% | 1,88% | 1.417.000 |
| 08/01/2008 | 51,25 | 51,25 | 49,05 | 49,31 | -4,39% | 4,30% | 3.169.200 |
| 07/01/2008 | 51,39 | 53,48 | 51,26 | 51,58 | +0,63% | 4,33% | 2.430.800 |